Therma Bright has secured a development and manufacturing deal with the medical device manufacturer K-One MediTech to market the Acuvid Covid-19 rapid antigen saliva test kit to the public. K-One will produce the test kits in Asia and the two-year agreement period will commence from the first batch of produced test kits for the commercial market.
Online at-home health testing provider empowerDX announced that its Covid-19 testing kit has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for children aged three years and older. It is the first test to receive such authorisation for at-home PCR nasal test for younger children. The company introduced its at-home Covid-19 test kit for consumers aged 18 years and older in the fall of 2020. The test kits are now available without a prescription on the company’s website, Amazon, via Uber’s on-demand deliver, and RiteAid.
Go deeper with GlobalData
Simon Fraser University researchers from Canada have approved a faster, and more cost-effective Covid-19 rapid test kit that is expected to scale the access and speed of rapid testing. The researchers have suggested that the test can be used in remote locations, airports, clinics, as it’s easy to administer and transport. The microchip test has the ability to provide accurate results within 30 minutes and requires ten times fewer reagents than in other approved RT-PCR tests.
